{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:45:18Z","timestamp":1779306318406,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T00:00:00Z","timestamp":1435190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/jhg.2015.61","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T06:21:56Z","timestamp":1435213316000},"page":"539-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations"],"prefix":"10.1038","volume":"60","author":[{"given":"Mohammad Arif","family":"Hossain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,25]]},"reference":[{"key":"BFjhg201561_CR1","unstructured":"Wenger, D. A., Escolar, M. L., Luzi, P. & Rafi, M. A . Krabbe disease (globoid cell leukodystrophy), in: Scriver\u2019s The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID). Available at http:\/\/ommbid.mhmedical.com\/content.aspx?bookid=474&sectionid=45374150 Accessed on 7 March 2014 (2013)."},{"key":"BFjhg201561_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1006\/bbrc.1994.1071","volume":"198","author":"N Sakai","year":"1994","unstructured":"Sakai, N., Inui, K., Fujii, N., Fukushima, H., Nishimoto, J., Yanagihara, I. et al. Krabbe disease: isolation and characterization of a full-length cDNA for human galactocerebrosidase. Biochem. Biophys. Res. Commun. 198, 485\u2013491 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFjhg201561_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0009-8981(98)00095-3","volume":"276","author":"S Nagano","year":"1998","unstructured":"Nagano, S., Yamada, T., Shinnoh, N., Furuya, H., Taniwaki, T. & Kira, J. Expression and processing of recombinant human galactosylceramidase. Clin. Chim. Acta 276, 53\u201361 (1998).","journal-title":"Clin. Chim. Acta"},{"key":"BFjhg201561_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","volume":"10","author":"DA Wenger","year":"1997","unstructured":"Wenger, D. A., Rafi, M. A. & Luzi, P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum. Mutat. 10, 268\u2013279 (1997).","journal-title":"Hum. Mutat."},{"key":"BFjhg201561_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.gene.2013.11.003","volume":"534","author":"MA Hossain","year":"2014","unstructured":"Hossain, M. A., Otomo, T., Saito, S., Ohno, K., Sakuraba, H., Hamada, Y. et al. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 534, 144\u2013154 (2014).","journal-title":"Gene"},{"key":"BFjhg201561_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1022436928925","volume":"23","author":"K Suzuki","year":"1998","unstructured":"Suzuki, K. Twenty five years of the \"psychosine hypothesis\": a personal perspective of its history and present status. Neurochem. Res. 23, 251\u2013259 (1998).","journal-title":"Neurochem. Res."},{"key":"BFjhg201561_CR7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S. et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease. N. Engl. J. Med. 352, 2069\u20132081 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFjhg201561_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1096\/fj.05-3826fje","volume":"19","author":"WC Lee","year":"2005","unstructured":"Lee, W. C., Courtenay, A., Troendle, F. J., Stallings-Mann, M. L., Dickey, C. A., DeLucia, M. W. et al. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy. FASEB J. 19, 1549\u20131551 (2005).","journal-title":"FASEB J."},{"key":"BFjhg201561_CR9","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1096\/fj.06-6169com","volume":"21","author":"WC Lee","year":"2007","unstructured":"Lee, W. C., Tsoi, Y. K., Troendle, F. J., DeLucia, M. W., Ahmed, Z., Dicky, C. A., Dickson, D. W. et al. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy. FASEB J. 21, 2520\u20132527 (2007).","journal-title":"FASEB J."},{"key":"BFjhg201561_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ab.2012.10.034","volume":"434","author":"J Ribbens","year":"2013","unstructured":"Ribbens, J., Whiteley, G., Furuya, H., Southall, N., Hu, X., Marugan, J. et al. A high-throughput screening assay using Krabbe disease patient cells. Analyt. Biochem. 434, 15\u201325 (2013).","journal-title":"Analyt. Biochem."},{"key":"BFjhg201561_CR11","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1523\/JNEUROSCI.6383-09.2010","volume":"30","author":"WC Lee","year":"2010","unstructured":"Lee, W. C., Kang, D., Causevic, E., Herdt, A. R., Eckman, E. A. & Eckman, C. B. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. J. Neurosci. 30, 5489\u20135497 (2010).","journal-title":"J. Neurosci."},{"key":"BFjhg201561_CR12","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0968-0896(02)00005-6","volume":"10","author":"S Ogawa","year":"2002","unstructured":"Ogawa, S., Matsunaga, Y. K. & Suzuki, Y. Chemical modification of the beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(beta-D-galactopyranosyl) derivatives. Bioorg. Med. Chem. 10, 1967\u20131972 (2002).","journal-title":"Bioorg. Med. Chem."},{"key":"BFjhg201561_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.braindev.2006.02.002","volume":"28","author":"H Iwasaki","year":"2006","unstructured":"Iwasaki, H., Watanabe, H., Iida, M., Ogawa, S., Tabe, M., Higaki, K. et al. Fibroblast screening for chaperone therapy in beta-galactosidosis. Brain Dev. 28, 482\u2013486 (2006).","journal-title":"Brain Dev."},{"key":"BFjhg201561_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/humu.21516","volume":"32","author":"K Higaki","year":"2011","unstructured":"Higaki, K., Li, L., Bahrudin, U., Okuzawa, S., Takamuram, A., Yamamoto, K. et al. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in \u03b2-galactosidase deficiency. Hum. Mutat. 32, 843\u2013852 (2011).","journal-title":"Hum. Mutat."},{"key":"BFjhg201561_CR15","doi-asserted-by":"publisher","first-page":"15912","DOI":"10.1073\/pnas.2536657100","volume":"100","author":"J Matsuda","year":"2003","unstructured":"Matsuda, J., Suzuki, O., Oshima, A., Yamamoto, Y., Noguchi, A., Takimoto, K. et al. Chemical chaperone therapy for brain pathology in GM1-gangliosidosis. Proc. Natl Acad. Sci. USA 100, 15912\u201315917 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201561_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ymgme.2012.02.012","volume":"106","author":"Y Suzuki","year":"2012","unstructured":"Suzuki, Y., Ichinomiya, S., Kurosawa, M., Matsuda, J., Ogawa, S., Iida, M. et al. Therapeutic chaperone effect of N-octyl 4-epi-\u03b2-valienamine on murine GM1-gangliosidosis. Mol. Genet. Metab. 106, 92\u201398 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201561_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"BFjhg201561_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali, A. & Blundell, T. L. Comparative protein modeling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779\u2013815 (1993).","journal-title":"J. Mol. Biol."},{"key":"BFjhg201561_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comp. Chem 31, 455\u2013461 (2010).","journal-title":"J. Comp. Chem"},{"key":"BFjhg201561_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ymgme.2008.12.017","volume":"96","author":"K Sugawara","year":"2009","unstructured":"Sugawara, K., Tajima, Y., Kawashima, I., Tsukimura, T., Saito, S., Ohno, K. et al. Molecular interaction of imino sugars with human alpha-galactosidase: insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease. Mol. Genet. Metab. 96, 233\u2013238 (2009).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201561_CR21","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/jhg.2011.36","volume":"56","author":"Y Tajima","year":"2011","unstructured":"Tajima, Y., Saito, S., Ohno, K., Tsukimura, T., Tsujino, S. & Sakuraba, H. Biochemical and structural study on a S529V mutant alpha-glucosidase responsive to pharmacological chaperones. J. Hum. Genet. 56, 440\u2013446 (2011).","journal-title":"J. Hum. Genet."},{"key":"BFjhg201561_CR22","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1074\/jbc.M609304200","volume":"282","author":"GH Maegawa","year":"2007","unstructured":"Maegawa, G. H., Tropak, M., Buttner, J., Stockley, T., Kok, F., Clarke, J. T. et al. Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis. J. Biol. Chem. 282, 9150\u20139161 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFjhg201561_CR23","doi-asserted-by":"publisher","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","volume":"284","author":"GH Maegawa","year":"2009","unstructured":"Maegawa, G. H., Tropak, M. B., Buttner, J. D., Rigat, B. A., Fuller, M., Pandit, D. et al. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease. J. Biol. Chem. 284, 23502\u201323516 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFjhg201561_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/jm1008902","volume":"54","author":"JJ Marugan","year":"2011","unstructured":"Marugan, J. J., Zheng, W., Motabar, O., Southall, N., Goldin, E., Westbroek, W. et al. Evaluation of quinazoline analogues as glucocerebrosidase inhibitors with chaperone activity. J. Med. Chem. 54, 1033\u20131058 (2011).","journal-title":"J. Med. Chem."},{"key":"BFjhg201561_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00216-011-5496-z","volume":"402","author":"O Motabar","year":"2012","unstructured":"Motabar, O., Goldin, E., Leister, W., Liu, K., Southall, N., Huang, W. et al. A high throughput glucocerebrosidase assay using the natural substrate glucosylceramide. Anal. Bioanal. Chem. 402, 731\u2013739 (2012).","journal-title":"Anal. Bioanal. Chem."},{"key":"BFjhg201561_CR26","doi-asserted-by":"publisher","first-page":"13192","DOI":"10.1073\/pnas.0705637104","volume":"104","author":"W Zheng","year":"2007","unstructured":"Zheng, W., Padia, J., Urban, D. J., Jadhav, A., Goker-Alpan, O., Simeonov, A. et al. Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proc. Natl Acad. Sci. USA 104, 13192\u201313197 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201561_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2010.09.004","volume":"102","author":"JT Clarke","year":"2011","unstructured":"Clarke, J. T., Mahuran, D. J., Sathe, S., Kolodny, E. H., Rigat, B. A., Raiman, J. A. et al. An open-label phase I\/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants). Mol. Genet. Metab. 102, 6\u201312 (2011).","journal-title":"Mol. Genet. Metab."},{"key":"BFjhg201561_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2183\/pjab.88.18","volume":"B 88","author":"S Ishii","year":"2012","unstructured":"Ishii, S. Pharmacological chaperone therapy for Fabry disease. Proc. Jpn. Acad B 88, 18\u201330 (2012).","journal-title":"Proc. Jpn. Acad"},{"key":"BFjhg201561_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","volume":"134","author":"TW Mu","year":"2008","unstructured":"Mu, T. W., Ong, D. S., Wang, Y. J., Balch, W. E., Yates, J. R., Segatori, L. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769\u2013781 (2008).","journal-title":"Cell"},{"key":"BFjhg201561_CR30","doi-asserted-by":"publisher","first-page":"15169","DOI":"10.1073\/pnas.1105639108","volume":"108","author":"JE Deane","year":"2011","unstructured":"Deane, J. E., Graham, S. C., Kim, N. N., Stein, P. E., McNair, R., Cach\u00f3n-Gonz\u00e1lez, M. B. et al. Insights into Krabbe disease from structures of galactocerebrosidase. Proc. Natl Acad. Sci. USA 108, 15169\u201315173 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFjhg201561_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1005449919660","volume":"22","author":"L Fu","year":"1999","unstructured":"Fu, L., Inui, K., Nishigaki, T., Tatsumi, N., Tsukamoto, H., Kokubu, C. et al. Molecular heterogeneity of Krabbe disease. J. Inher. Metab. Dis 22, 155\u2013162 (1999).","journal-title":"J. Inher. Metab. Dis"},{"key":"BFjhg201561_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000112332","volume":"6","author":"E Conzelmann","year":"1983","unstructured":"Conzelmann, E. & Sandhoff, K. Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev. Neurosci. 6, 58\u201371 (1983).","journal-title":"Dev. Neurosci."}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg201561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201561","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg201561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T18:04:24Z","timestamp":1717956264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg201561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFjhg201561"],"URL":"https:\/\/doi.org\/10.1038\/jhg.2015.61","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,25]]},"assertion":[{"value":"11 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}